A Practitioner’s Look at Merger Control Remedies in China

Francois Renard, Jan 25, 2012

Since the entry into force of its antitrust rules, China has approved transactions subject to “restrictive conditions,” also called “remedies” or “commitments” in other jurisdictions, in only ten out of approximately 370 transactions notified. This is a particularly low proportion of cases compared to other jurisdictions, including the European Union. This shows that instead of prohibiting these transactions, the Chinese competition authority has preferred to opt for a favorable outcome allowing companies to proceed with their operation, which must be welcomed.

The …

ACCESS TO THIS ARTICLE IS RESTRICTED TO SUBSCRIBERS

Please sign in or join us
to access premium content!